Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review

F Nabizadeh, E Ramezannezhad… - Journal of Clinical …, 2022 - Elsevier
Background Concerns about vaccination increased among patients with multiple sclerosis
(MS) regarding side effects, efficacy, and disease exacerbation. Recently there were reports …

Contradictory regulation of macrophages on atherosclerosis based on polarization, death and autophagy

J Zhang, CR Ma, YQ Hua, L Li, JY Ni, YT Huang… - Life sciences, 2021 - Elsevier
The main pathological feature of atherosclerosis is lipid metabolism disorder and
inflammation. Macrophages, as the most important immune cells in the body, run through the …

New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19

YD Fragoso, S Gomes, MVM Gonçalves… - Multiple sclerosis and …, 2022 - Elsevier
We report on nine patients (eight cases of MS and one case of NMOSD) who presented a
disease relapse in close temporal association with their first AZD1222 vaccination dose …

Low level of plasminogen increases risk for mortality in COVID-19 patients

D Della-Morte, F Pacifici, C Ricordi, R Massoud… - Cell death & …, 2021 - nature.com
The pathophysiology of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), and especially of its complications is still …

Necroptosis contributes to persistent inflammation during acute leptospirosis

S Kundu, A Shetty, M Gomes-Solecki - Frontiers in immunology, 2022 - frontiersin.org
Leptospirosis is an emerging infectious disease. Recently, canine and human leptospirosis
outbreaks were reported in California and New York, respectively. In this study we evaluated …

Frequency and predictors of relapses following SARS-CoV-2 vaccination in patients with multiple sclerosis: interim results from a longitudinal observational study

N Frahm, F Fneish, D Ellenberger, J Haas… - Journal of Clinical …, 2023 - mdpi.com
Despite protection from severe COVID-19 courses through vaccinations, some people with
multiple sclerosis (PwMS) are vaccination-hesitant due to fear of post-vaccination side …

No time to die: how kidney cancer evades cell death

C Ganini, M Montanaro, M Scimeca, G Palmieri… - International Journal of …, 2022 - mdpi.com
The understanding of the pathogenesis of renal cell carcinoma led to the development of
targeted therapies, which dramatically changed the overall survival rate. Nonetheless …

NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network

E Mammarella, C Zampieri, E Panatta, G Melino… - Biology Direct, 2021 - Springer
Most inactivating mutations in TP53 gene generates neomorphic forms of p53 proteins that
experimental evidence and clinical observations suggest to exert gain-of-function effects …

[HTML][HTML] Engineering materials for pyroptosis induction in cancer treatment

J Liu, T Chen, XL Liu, ZH Li, Y Zhang - Bioactive Materials, 2024 - Elsevier
Cancer remains a significant global health concern, necessitating the development of
innovative therapeutic strategies. This research paper aims to investigate the role of …

Occurrence and risk factors of relapse activity after vaccination against COVID-19 in people with multiple sclerosis: 1-year follow-up results from a nationwide …

F Fneish, N Frahm, M Peters, D Ellenberger, J Haas… - Vaccines, 2023 - mdpi.com
Several studies reported post-SARS-CoV-2-vaccination (PV) symptoms. Even people with
multiple sclerosis (PwMS) have concerns about disease activity following the SARS-CoV-2 …